Sacubitril-valsartan — a combination oral therapy approved to treat heart failure — rapidly reduces pulmonary blood pressure in people with…
Articles by Marta Figueiredo, PhD
The blood levels of a signaling molecule called fibroblast growth factor 21 (FGF21) are significantly reduced in people with high-altitude…
A receptor protein at the surface of lung vascular progenitor cells regulates the cells’ growth and maturation into smooth muscle…
Maternal and fetal complications are frequent across pulmonary hypertension (PH) groups, with about a third of patients experiencing an…
Ferrer has acquired exclusive rights to commercialize Tyvaso (inhaled treprostinil) for the treatment of pulmonary hypertension associated…
The composition of certain bacteria in the gut is significantly altered and associated with greater disease severity in people with…
Rac1, an enzyme involved in blood pressure regulation, is overly active in pulmonary artery smooth muscle cells (PASMCs) — the…
Among people selected for kidney transplant, the presence of pre-transplant pulmonary hypertension (PH) is associated with an increased risk…
Researchers in the U.K. will evaluate whether the levels of NT-proBNP — a heart damage biomarker that serves as a…
High blood levels of NT-proBNP — a validated and widely accepted prognostic marker of pulmonary hypertension (PH) — may…
Increased lung arterial obstruction is significantly associated with greater airflow obstruction in people with chronic thromboembolic pulmonary hypertension (CTEPH)…
Aerami Therapeutics, a biopharmaceutical company focused on developing inhaled therapies for severe respiratory diseases — including pulmonary arterial…